These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20529095)

  • 1. Role of endothelin in the effects of isoprenaline on potassium currents and calsequestrin 2 expression in the heart.
    Li N; Jia N; Dai DZ; Hu C; Dai Y
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):557-63. PubMed ID: 20529095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors.
    Feng Y; Tang XY; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2007 Nov; 28(11):1746-54. PubMed ID: 17959025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon.
    Li N; Jia N; Dai DZ; Dai Y
    Eur J Pharmacol; 2008 Sep; 591(1-3):211-8. PubMed ID: 18611397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats.
    Xu M; Ji H; Dai DZ; Tang XY; Dai Y
    J Pharm Pharmacol; 2008 Jun; 60(6):739-45. PubMed ID: 18498710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-induced cardiac insufficiency relating to abnormal leptin and FKBP12.6 is ameliorated by CPU0213, an endothelin receptor antagonist, which is not affected by the CYP3A suppressing effect of erythromycin.
    Cheng YS; Dai DZ; Dai Y
    J Pharm Pharmacol; 2009 May; 61(5):569-76. PubMed ID: 19405994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatment.
    Luo L; Dai DZ; Dai Y
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):757-65. PubMed ID: 18215179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats.
    Qi MY; Xia HJ; Dai DZ; Dai Y
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):729-35. PubMed ID: 16810072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature.
    Xu J; Li N; Dai DZ; Yu F; Dai Y
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):42-8. PubMed ID: 18594475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.
    Johnson DM; Heijman J; Pollard CE; Valentin JP; Crijns HJ; Abi-Gerges N; Volders PG
    J Mol Cell Cardiol; 2010 Jan; 48(1):122-30. PubMed ID: 19744496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testis dysfunction by isoproterenol is mediated by upregulating endothelin receptor A, leptin and protein kinase Cvarepsilon and is attenuated by an endothelin receptor antagonist CPU0213.
    Cheng YS; Dai DZ; Dai Y
    Reprod Toxicol; 2010 Jul; 29(4):421-6. PubMed ID: 20307649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway.
    He HB; Yu F; Dai DZ; Dai Y
    J Pharm Pharmacol; 2007 Jul; 59(7):977-84. PubMed ID: 17637193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by endothelin-1 of Na+-Ca2+ exchange current (I(NaCa)) from guinea-pig isolated ventricular myocytes.
    Zhang YH; James AF; Hancox JC
    Cell Calcium; 2001 Nov; 30(5):351-60. PubMed ID: 11733942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic stimulation reverses the I Kr-I Ks dominant pattern during cardiac action potential.
    Banyasz T; Jian Z; Horvath B; Khabbaz S; Izu LT; Chen-Izu Y
    Pflugers Arch; 2014 Nov; 466(11):2067-76. PubMed ID: 24535581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AQP4 knockout mice manifest abnormal expressions of calcium handling proteins possibly due to exacerbating pro-inflammatory factors in the heart.
    Cheng YS; Tang YQ; Dai DZ; Dai Y
    Biochem Pharmacol; 2012 Jan; 83(1):97-105. PubMed ID: 22020118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
    Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The separate roles of endothelin receptors participate in remodeling of matrix metalloproteinase and connexin 43 of cardiac fibroblasts in maladaptive response to isoproterenol.
    Peng HJ; Dai DZ; Ji H; Dai Y
    Eur J Pharmacol; 2010 May; 634(1-3):101-6. PubMed ID: 20167215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats.
    Xu M; Dai DZ; Dai Y
    Am J Nephrol; 2009; 29(3):252-6. PubMed ID: 18802327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin.
    Zhang Y; Huang ZJ; Dai DZ; Feng Y; Na T; Tang XY; Dai Y
    Int J Cardiol; 2008 Nov; 130(3):463-71. PubMed ID: 18684528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of action potential configuration and the contribution of C²⁺a and K⁺ currents to isoprenaline-induced changes in canine ventricular cells.
    Szentandrássy N; Farkas V; Bárándi L; Hegyi B; Ruzsnavszky F; Horváth B; Bányász T; Magyar J; Márton I; Nánási PP
    Br J Pharmacol; 2012 Oct; 167(3):599-611. PubMed ID: 22563726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.
    Ruzsnavszky F; Hegyi B; Kistamás K; Váczi K; Horváth B; Szentandrássy N; Bányász T; Nánási PP; Magyar J
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):457-67. PubMed ID: 24566722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.